Cell Harvesting Systems Market size was around USD 3.8 billion in 2018. It is expected to grow at a CAGR of 13.7% to reach USD 7.2 billion by 2023.
Cell harvesting is a technique where stem cells are utilized in regeneration and transplanting the damaged organs with healthy ones. Cell harvesting technique is expected to lead in the future of biopharmaceutical industry with a wide scope ranging from the regeneration of skin in burn victims to treating cancers.
The increasing demand for cell regeneration as a treatment for chronic conditions is a key driver behind the growth of the Cell Harvesting market. Other factors like increasing stem cell transplantation rate and rising investment in stem cell research also have a positive impact on the growth of the Cell Harvesting market. However, the cumbersomeness of the treatment, complications arising during the cell harvesting, high cost, and subsequent lack of sufficient reimbursement policies prove to be restraining the growth of the market.
The market is segmented by application, by end-user, and by the technique. According to type, the market is sub-segmented into Bone Marrow, Umbilical Cord, Adipose Tissue and Peripheral Blood. The application segment is dominated by Peripheral Blood and is forecast to maintain its dominance in the years to come. Under end-user, the market of further categorized into Academic Institutes, Hospitals, Diagnostic Labs and Research Institutes. Because a major part of cell harvesting for stem cell regeneration is done in hospitals, hospitals lead the end-use segment of the market and are expected to retain its top position in the forecast period. The growth of stem cell harvesting in academic institutes is also estimated to be fuelled by the rise in research on cell harvesting. By technique, the market is further classified into Blastomere Extraction and Altered Nuclear Transfer.
The market is also segmented geographically into Asia Pacific, Europe, Middle East & Africa, Latin America and North America. Given the higher rate of stem cell research and transplantation, North America and Europe dominate the market. Increase in prevalence of cancer and the rise in aging population also propels the market growth in these areas.
The leading players in the current market are Avita Medical; Tomtec; Terumo Corporation; Perkin Elmer, Inc; Argos Technologies, Inc; Bertin Technologies; Arthrex, Inc; Brand GmBh + CO KG; Thomas Scientific; and Tereflex, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Bone Marrow
5.1.2 Umbilical Cord
5.1.3 Adipose Tissue
5.1.4 Peripheral Blood
5.1.5 Y-o-Y Growth Analysis, By Application
5.1.6 Market Attractiveness Analysis, By Application
5.1.7 Market Share Analysis, By Application
5.2 End-user
5.2.1 Academic Institues
5.2.2 Hospitals
5.2.3 Diagnostic Labs
5.2.4 Research Centers
5.2.5 Y-o-Y Growth Analysis, By End-user
5.2.6 Market Attractiveness Analysis, By End-user
5.2.7 Market Share Analysis, By End-user
5.3 Technique
5.3.1 Blastomere Extraction
5.3.2 Altered Nuclear Transfer
5.3.3 Y-o-Y Growth Analysis, By Technique
5.3.4 Market Attractiveness Analysis, By Technique
5.3.5 Market Share Analysis, By Technique
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By End-user
6.1.3.4 By Techniue
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By End-user
6.1.4.4 By Technique
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By End-user
6.1.5.4 By Technique
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Avita Medical
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tomtec
8.3 Terumo Corporation
8.4 Perkin Elmer, Inc
8.5 Argos Technologies
8.6 Bertin
8.7 Arthrex, Inc
8.8 Brand GmBh + CO KG
8.9 Thomas Scientific
8.10 Tereflex, Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
